NASDAQ:SCYX - SCYNEXIS News Headlines

Sign in or create an account to add this stock to your watchlist.
$1.85 -0.01 (-0.54 %)
(As of 07/20/2018 01:54 PM ET)
Previous Close$1.85
Today's Range$1.83 - $1.85
52-Week Range$1.05 - $2.50
Volume12,019 shs
Average Volume950,900 shs
Market Capitalization$87.13 million
P/E Ratio-1.83
Dividend YieldN/A
Beta0.49

Headlines

SCYNEXIS (NASDAQ SCYX) News Headlines

Source:
DateHeadline
SCYNEXIS Inc (SCYX) Receives Average Rating of "Buy" from BrokeragesSCYNEXIS Inc (SCYX) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - July 19 at 2:16 AM
The World Health Organization Recognizes New Antifungal Class by Granting "ibrexafungerp" to SCYNEXIS as the International Non-Proprietary Name for SCY-078The World Health Organization Recognizes New Antifungal Class by Granting "ibrexafungerp" to SCYNEXIS as the International Non-Proprietary Name for SCY-078
finance.yahoo.com - July 18 at 4:53 PM
$80,000.00 in Sales Expected for SCYNEXIS Inc (SCYX) This Quarter$80,000.00 in Sales Expected for SCYNEXIS Inc (SCYX) This Quarter
www.americanbankingnews.com - July 14 at 10:28 PM
Week Ahead In Pharmaceuticals - 7 Stocks To WatchWeek Ahead In Pharmaceuticals - 7 Stocks To Watch
www.nasdaq.com - July 14 at 3:39 PM
SCYNEXIS: An Update On This ~$2 Lottery TicketSCYNEXIS: An Update On This ~$2 'Lottery Ticket'
seekingalpha.com - July 14 at 3:39 PM
SCYNEXIS Inc (SCYX) Expected to Announce Earnings of -$0.14 Per ShareSCYNEXIS Inc (SCYX) Expected to Announce Earnings of -$0.14 Per Share
www.americanbankingnews.com - July 12 at 10:16 PM
Why Scynexis Stock Rose 16.4% YesterdayWhy Scynexis Stock Rose 16.4% Yesterday
finance.yahoo.com - July 12 at 4:49 PM
Biotech Analysis Central Pharma News: Pfizers Unit Separation, BioCrysts Merger Collapses, Scynexis Positive Mid-Stage ResultsBiotech Analysis Central Pharma News: Pfizer's Unit Separation, BioCryst's Merger Collapses, Scynexis' Positive Mid-Stage Results
seekingalpha.com - July 12 at 8:15 AM
SCYNEXIS (SCYX) Upgraded to Buy by Needham & Company LLCSCYNEXIS (SCYX) Upgraded to Buy by Needham & Company LLC
www.americanbankingnews.com - July 11 at 11:26 AM
HC Wainwright Analysts Give SCYNEXIS (SCYX) a $5.00 Price TargetHC Wainwright Analysts Give SCYNEXIS (SCYX) a $5.00 Price Target
www.americanbankingnews.com - July 11 at 11:15 AM
SCYNEXIS selects dose regimen for late-stage studies of antifungal SCY-078SCYNEXIS selects dose regimen for late-stage studies of antifungal SCY-078
seekingalpha.com - July 11 at 8:12 AM
Scynexis (SCYX) Reports Positive Results from Phase 2b Dose-Finding Study of Oral SCY-078 in VVCScynexis (SCYX) Reports Positive Results from Phase 2b Dose-Finding Study of Oral SCY-078 in VVC
www.streetinsider.com - July 10 at 5:00 PM
SCYNEXIS Reports Positive Results from Phase 2b Dose-Finding Study of Oral SCY-078 in Vulvovaginal CandidiasisSCYNEXIS Reports Positive Results from Phase 2b Dose-Finding Study of Oral SCY-078 in Vulvovaginal Candidiasis
finance.yahoo.com - July 10 at 5:00 PM
Complimentary Technical Snapshots on Mylan and Three More Generic Drugs StocksComplimentary Technical Snapshots on Mylan and Three More Generic Drugs Stocks
finance.yahoo.com - July 2 at 8:23 AM
SCYNEXIS (SCYX) Rating Reiterated by Canaccord GenuitySCYNEXIS (SCYX) Rating Reiterated by Canaccord Genuity
www.americanbankingnews.com - June 29 at 9:18 AM
SCYNEXIS (SCYX) Now Covered by Maxim GroupSCYNEXIS (SCYX) Now Covered by Maxim Group
www.americanbankingnews.com - June 27 at 11:32 AM
SCYNEXIS Announces the Presentation of SCY-078 Data at the Teratology Society 58th Annual MeetingSCYNEXIS Announces the Presentation of SCY-078 Data at the Teratology Society 58th Annual Meeting
finance.yahoo.com - June 27 at 8:48 AM
SCYNEXIS Inc (SCYX) Expected to Post Quarterly Sales of $80,000.00SCYNEXIS Inc (SCYX) Expected to Post Quarterly Sales of $80,000.00
www.americanbankingnews.com - June 27 at 3:48 AM
Scynexis, Undervalued And Filling A Critical Need In The Antifungal SpaceScynexis, Undervalued And Filling A Critical Need In The Antifungal Space
seekingalpha.com - June 26 at 5:20 PM
Zacks: Brokerages Anticipate SCYNEXIS Inc (SCYX) Will Post Earnings of -$0.14 Per ShareZacks: Brokerages Anticipate SCYNEXIS Inc (SCYX) Will Post Earnings of -$0.14 Per Share
www.americanbankingnews.com - June 25 at 1:30 PM
SCYNEXIS Inc (SCYX) Receives Consensus Recommendation of "Buy" from AnalystsSCYNEXIS Inc (SCYX) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - June 24 at 3:04 AM
Form 8-K SCYNEXIS INC For: Jun 14Form 8-K SCYNEXIS INC For: Jun 14
www.streetinsider.com - June 22 at 5:45 PM
SCYNEXIS Inc (SCYX) Short Interest UpdateSCYNEXIS Inc (SCYX) Short Interest Update
www.americanbankingnews.com - June 15 at 3:44 AM
SCYNEXIS to Present SCY-078 Data at Three Scientific Meetings in June/July 2018SCYNEXIS to Present SCY-078 Data at Three Scientific Meetings in June/July 2018
finance.yahoo.com - June 14 at 8:18 AM
SCYNEXIS Presents SCY-078 Data at ASM Microbe 2018SCYNEXIS Presents SCY-078 Data at ASM Microbe 2018
finance.yahoo.com - June 11 at 5:14 PM
Your Daily Pharma Scoop: Scynexis Moves Up, Proteostasis Disappoints Investors, Cellectar ZoomsYour Daily Pharma Scoop: Scynexis Moves Up, Proteostasis Disappoints Investors, Cellectar Zooms
seekingalpha.com - June 11 at 8:12 AM
SCYNEXIS Inc (SCYX) Expected to Announce Quarterly Sales of $80,000.00SCYNEXIS Inc (SCYX) Expected to Announce Quarterly Sales of $80,000.00
www.americanbankingnews.com - June 10 at 4:16 AM
SCYNEXIS announces publication of early-stage SCY-078 data; shares up 2% premarketSCYNEXIS announces publication of early-stage SCY-078 data; shares up 2% premarket
seekingalpha.com - June 6 at 5:31 PM
SCYNEXIS Inc (SCYX) Given Consensus Rating of "Buy" by BrokeragesSCYNEXIS Inc (SCYX) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - May 30 at 3:12 AM
SCYNEXIS to Present SCY-078 Data at ASM Microbe 2018SCYNEXIS to Present SCY-078 Data at ASM Microbe 2018
finance.yahoo.com - May 24 at 5:46 PM
SCYNEXIS (SCYX) Now Covered by Analysts at Ladenburg ThalmannSCYNEXIS (SCYX) Now Covered by Analysts at Ladenburg Thalmann
www.americanbankingnews.com - May 24 at 1:14 PM
 Brokerages Anticipate SCYNEXIS Inc (SCYX) Will Announce Quarterly Sales of $80,000.00 Brokerages Anticipate SCYNEXIS Inc (SCYX) Will Announce Quarterly Sales of $80,000.00
www.americanbankingnews.com - May 24 at 9:05 AM
Free Daily Technical Summary Reports on Mylan and Three Other Generic Drugs StocksFree Daily Technical Summary Reports on Mylan and Three Other Generic Drugs Stocks
finance.yahoo.com - May 24 at 8:15 AM
SCYNEXIS to Participate in a Panel at the 2018 BIO International ConventionSCYNEXIS to Participate in a Panel at the 2018 BIO International Convention
finance.yahoo.com - May 23 at 5:40 PM
What’s Behind the 28% Hike in SCYNEXIS Stock Last Week?What’s Behind the 28% Hike in SCYNEXIS Stock Last Week?
finance.yahoo.com - May 22 at 8:16 AM
Zacks: Analysts Expect Scynexis (SCYX) to Post -$0.14 Earnings Per ShareZacks: Analysts Expect Scynexis (SCYX) to Post -$0.14 Earnings Per Share
www.americanbankingnews.com - May 22 at 1:16 AM
Seaport Global Securities Comments on Scynexis Q2 2018 Earnings (SCYX)Seaport Global Securities Comments on Scynexis' Q2 2018 Earnings (SCYX)
www.americanbankingnews.com - May 18 at 7:08 AM
Financial Analysis: Retrophin (RTRX) versus Scynexis (SCYX)Financial Analysis: Retrophin (RTRX) versus Scynexis (SCYX)
www.americanbankingnews.com - May 13 at 11:16 PM
Scynexis (SCYX) Issues Quarterly  Earnings ResultsScynexis (SCYX) Issues Quarterly Earnings Results
www.americanbankingnews.com - May 9 at 1:31 PM
SCYNEXIS beats by $0.08, misses on revenueSCYNEXIS beats by $0.08, misses on revenue
seekingalpha.com - May 9 at 8:15 AM
Scynexis: 1Q Earnings SnapshotScynexis: 1Q Earnings Snapshot
finance.yahoo.com - May 9 at 8:14 AM
SCYNEXIS Reports First Quarter 2018 Financial Results and Provides Company UpdateSCYNEXIS Reports First Quarter 2018 Financial Results and Provides Company Update
finance.yahoo.com - May 8 at 5:45 PM
Scynexis (SCYX) Earns Buy Rating from Analysts at Roth CapitalScynexis (SCYX) Earns Buy Rating from Analysts at Roth Capital
www.americanbankingnews.com - May 8 at 2:46 PM
Scynexis (SCYX) Upgraded by Zacks Investment Research to "Buy"Scynexis (SCYX) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - May 8 at 11:02 AM
Roth Capital Assumes SCYNEXIS (SCYX) at BuyRoth Capital Assumes SCYNEXIS (SCYX) at Buy
www.streetinsider.com - May 8 at 8:12 AM
Benzingas Top Upgrades, Downgrades For May 7, 2018Benzinga's Top Upgrades, Downgrades For May 7, 2018
www.benzinga.com - May 7 at 5:43 PM
Scynexis (SCYX) "Buy" Rating Reaffirmed at HC WainwrightScynexis' (SCYX) "Buy" Rating Reaffirmed at HC Wainwright
www.americanbankingnews.com - May 7 at 2:58 PM
UPDATE: HC Wainwright Starts SCYNEXIS (SCYX) at BuyUPDATE: HC Wainwright Starts SCYNEXIS (SCYX) at Buy
www.streetinsider.com - May 7 at 8:15 AM
Scynexis (SCYX) Given Consensus Rating of "Buy" by AnalystsScynexis (SCYX) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - May 5 at 3:33 AM
Scynexis (SCYX) Upgraded to Hold by ValuEngineScynexis (SCYX) Upgraded to Hold by ValuEngine
www.americanbankingnews.com - May 2 at 6:02 PM
This page was last updated on 7/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.